CADENCE CAPITAL MANAGEMENT LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2015$1,116,000
+9.8%
67,274
+0.3%
0.07%
+15.3%
Q4 2014$1,016,000
-1.1%
67,085
-7.5%
0.06%
+9.3%
Q3 2014$1,027,000
-2.7%
72,537
-2.7%
0.05%
+5.9%
Q2 2014$1,055,000
-25.5%
74,517
-9.9%
0.05%
-15.0%
Q1 2014$1,417,000
+40.9%
82,715
+20.8%
0.06%
+57.9%
Q4 2013$1,006,000
+195.0%
68,470
+166.3%
0.04%
+216.7%
Q3 2013$341,00025,7140.01%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 362,166$5,371,0004.20%
KELLEHER FINANCIAL ADVISORS 135,838$2,014,0001.15%
NAPLES GLOBAL ADVISORS, LLC 67,032$994,0000.48%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 193,500$2,870,0000.36%
North Star Investment Management Corp. 112,950$1,675,0000.31%
Uniplan Investment Counsel, Inc. 364,831$5,410,0000.25%
Moors & Cabot, Inc. 98,374$1,450,0000.24%
RBF Capital, LLC 78,495$1,164,0000.22%
CARL DOMINO INC 20,272$301,0000.20%
Granite Investment Partners, LLC 70,435$1,044,0000.10%
View complete list of PSYCHEMEDICS CORP shareholders